Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Immunotherapy
1.2.3 Chemotherapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pediatric Neuroblastoma Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Neuroblastoma Treatment Market Perspective (2018-2033)
2.2 Pediatric Neuroblastoma Treatment Growth Trends by Region
2.2.1 Global Pediatric Neuroblastoma Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Pediatric Neuroblastoma Treatment Historic Market Size by Region (2018-2023)
2.2.3 Pediatric Neuroblastoma Treatment Forecasted Market Size by Region (2024-2033)
2.3 Pediatric Neuroblastoma Treatment Market Dynamics
2.3.1 Pediatric Neuroblastoma Treatment Industry Trends
2.3.2 Pediatric Neuroblastoma Treatment Market Drivers
2.3.3 Pediatric Neuroblastoma Treatment Market Challenges
2.3.4 Pediatric Neuroblastoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue
3.1.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue (2018-2023)
3.1.2 Global Pediatric Neuroblastoma Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Pediatric Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Neuroblastoma Treatment Revenue
3.4 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio
3.4.1 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Neuroblastoma Treatment Revenue in 2022
3.5 Pediatric Neuroblastoma Treatment Key Players Head office and Area Served
3.6 Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
3.7 Date of Enter into Pediatric Neuroblastoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Neuroblastoma Treatment Breakdown Data by Type
4.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Type (2018-2023)
4.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2024-2033)
5 Pediatric Neuroblastoma Treatment Breakdown Data by Application
5.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Application (2018-2023)
5.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Pediatric Neuroblastoma Treatment Market Size (2018-2033)
6.2 North America Pediatric Neuroblastoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Pediatric Neuroblastoma Treatment Market Size by Country (2018-2023)
6.4 North America Pediatric Neuroblastoma Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Neuroblastoma Treatment Market Size (2018-2033)
7.2 Europe Pediatric Neuroblastoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2018-2023)
7.4 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size (2018-2033)
8.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Neuroblastoma Treatment Market Size (2018-2033)
9.2 Latin America Pediatric Neuroblastoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2018-2023)
9.4 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size (2018-2033)
10.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 United Therapeutics
11.1.1 United Therapeutics Company Detail
11.1.2 United Therapeutics Business Overview
11.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Introduction
11.1.4 United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023)
11.1.5 United Therapeutics Recent Development
11.2 Apeiron Biologics
11.2.1 Apeiron Biologics Company Detail
11.2.2 Apeiron Biologics Business Overview
11.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Introduction
11.2.4 Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023)
11.2.5 Apeiron Biologics Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pediatric Neuroblastoma Treatment Introduction
11.3.4 Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Pediatric Neuroblastoma Treatment Introduction
11.4.4 Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023)
11.4.5 Bayer Recent Development
11.5 Baxter
11.5.1 Baxter Company Detail
11.5.2 Baxter Business Overview
11.5.3 Baxter Pediatric Neuroblastoma Treatment Introduction
11.5.4 Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023)
11.5.5 Baxter Recent Development
11.6 Cellectar Biosciences
11.6.1 Cellectar Biosciences Company Detail
11.6.2 Cellectar Biosciences Business Overview
11.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Introduction
11.6.4 Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023)
11.6.5 Cellectar Biosciences Recent Development
11.7 MacroGenics
11.7.1 MacroGenics Company Detail
11.7.2 MacroGenics Business Overview
11.7.3 MacroGenics Pediatric Neuroblastoma Treatment Introduction
11.7.4 MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023)
11.7.5 MacroGenics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Others
Table 5. Global Pediatric Neuroblastoma Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Pediatric Neuroblastoma Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Pediatric Neuroblastoma Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Pediatric Neuroblastoma Treatment Market Share by Region (2018-2023)
Table 9. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Pediatric Neuroblastoma Treatment Market Share by Region (2024-2033)
Table 11. Pediatric Neuroblastoma Treatment Market Trends
Table 12. Pediatric Neuroblastoma Treatment Market Drivers
Table 13. Pediatric Neuroblastoma Treatment Market Challenges
Table 14. Pediatric Neuroblastoma Treatment Market Restraints
Table 15. Global Pediatric Neuroblastoma Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Pediatric Neuroblastoma Treatment Market Share by Players (2018-2023)
Table 17. Global Top Pediatric Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2022)
Table 18. Ranking of Global Top Pediatric Neuroblastoma Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Pediatric Neuroblastoma Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
Table 22. Date of Enter into Pediatric Neuroblastoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediatric Neuroblastoma Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2024-2033)
Table 28. Global Pediatric Neuroblastoma Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Application (2024-2033)
Table 32. North America Pediatric Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Pediatric Neuroblastoma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Pediatric Neuroblastoma Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Pediatric Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Pediatric Neuroblastoma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Pediatric Neuroblastoma Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Pediatric Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. United Therapeutics Company Detail
Table 48. United Therapeutics Business Overview
Table 49. United Therapeutics Pediatric Neuroblastoma Treatment Product
Table 50. United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023) & (US$ Million)
Table 51. United Therapeutics Recent Development
Table 52. Apeiron Biologics Company Detail
Table 53. Apeiron Biologics Business Overview
Table 54. Apeiron Biologics Pediatric Neuroblastoma Treatment Product
Table 55. Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023) & (US$ Million)
Table 56. Apeiron Biologics Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Pediatric Neuroblastoma Treatment Product
Table 60. Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Bayer Company Detail
Table 63. Bayer Business Overview
Table 64. Bayer Pediatric Neuroblastoma Treatment Product
Table 65. Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Baxter Company Detail
Table 68. Baxter Business Overview
Table 69. Baxter Pediatric Neuroblastoma Treatment Product
Table 70. Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023) & (US$ Million)
Table 71. Baxter Recent Development
Table 72. Cellectar Biosciences Company Detail
Table 73. Cellectar Biosciences Business Overview
Table 74. Cellectar Biosciences Pediatric Neuroblastoma Treatment Product
Table 75. Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023) & (US$ Million)
Table 76. Cellectar Biosciences Recent Development
Table 77. MacroGenics Company Detail
Table 78. MacroGenics Business Overview
Table 79. MacroGenics Pediatric Neuroblastoma Treatment Product
Table 80. MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2018-2023) & (US$ Million)
Table 81. MacroGenics Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Neuroblastoma Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Pediatric Neuroblastoma Treatment Market Share by Type: 2022 VS 2033
Figure 3. Immunotherapy Features
Figure 4. Chemotherapy Features
Figure 5. Others Features
Figure 6. Global Pediatric Neuroblastoma Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Pediatric Neuroblastoma Treatment Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Pediatric Neuroblastoma Treatment Report Years Considered
Figure 12. Global Pediatric Neuroblastoma Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Pediatric Neuroblastoma Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Pediatric Neuroblastoma Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Pediatric Neuroblastoma Treatment Market Share by Players in 2022
Figure 16. Global Top Pediatric Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Pediatric Neuroblastoma Treatment Revenue in 2022
Figure 18. North America Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Pediatric Neuroblastoma Treatment Market Share by Country (2018-2033)
Figure 20. United States Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Pediatric Neuroblastoma Treatment Market Share by Country (2018-2033)
Figure 24. Germany Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Pediatric Neuroblastoma Treatment Market Share by Region (2018-2033)
Figure 32. China Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Pediatric Neuroblastoma Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Pediatric Neuroblastoma Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. United Therapeutics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2018-2023)
Figure 47. Apeiron Biologics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2018-2023)
Figure 48. Pfizer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2018-2023)
Figure 49. Bayer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2018-2023)
Figure 50. Baxter Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2018-2023)
Figure 51. Cellectar Biosciences Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2018-2023)
Figure 52. MacroGenics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed